Invention Grant
- Patent Title: Chemosensory receptor ligand-based therapies
-
Application No.: US15289713Application Date: 2016-10-10
-
Publication No.: US09962344B2Publication Date: 2018-05-08
- Inventor: Alain D. Baron , Nigel R. A. Beeley , Mark S. Fineman
- Applicant: ELCELYX THERAPEUTICS, INC.
- Applicant Address: US CA San Diego
- Assignee: ELCELYX THERAPEUTICS, INC.
- Current Assignee: ELCELYX THERAPEUTICS, INC.
- Current Assignee Address: US CA San Diego
- Agent Todd A. Lorenz
- Main IPC: A61K31/155
- IPC: A61K31/155 ; A61K9/20 ; A61K9/24 ; A61K9/28 ; A61K9/48 ; A61K9/00 ; A61K31/19 ; A61K31/198 ; A61K31/7016 ; A61K31/704 ; A61K45/06

Abstract:
Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a chemosensory receptor ligand, such as a bitter receptor ligand. Also provided herein are chemosensory receptor ligand compositions, including bitter receptor ligand compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
Public/Granted literature
- US20170020829A1 Chemosensory Receptor Ligand-Based Therapies Public/Granted day:2017-01-26
Information query